Vaxxas Home


Vaccine Application System using Nanopatch™ Technology

Welcome to Vaxxas

Vaxxas is pioneering a next-generation vaccine delivery platform that enables robust immune system activation by targeting vaccine components to the abundant immunological cells immediately below the surface of the skin. Vaxxas' proprietary Nanopatch™ technology aims to provide an optimized, differentiated needle-free vaccine delivery solution that safely and cost effectively amplifies vaccine efficacy.

Application of the Nanopatch™ to the skin is a pain-free method of vaccine delivery and has been shown in preclinical studies to result in a protective immunogenic response, using as little as one hundredth of the dose required by conventional needle and syringe. The robust immune response inherent to Nanopatch-delivered vaccines can also enable reduction or elimination of additives such as adjuvants and proprietary dry-coating of vaccine to the Nanopatch™ can eliminate the need for refrigeration during storage and transportation.

What is the


Nanopatch overview

The Nanopatch™

approach consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin...

More >

Benefits of the


Nanopatch benefits

The key features

of the Nanopatch™ delivery technology include improved immunogenicity, needle and pain free vaccine delivery with no cold chain...

More >


News from Vaxxas